Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 23, 2004

View Archived Issues

NQOI inducer dimethylfumarate boosts mitomycin C antitumor activity in vivo

Add-on Uvadex therapy reported to improve outcome in patients receiving ASCT

New data on the benefits of omega-3 fatty acid supplementation in chronic epilepsy

DURIN leuprolide acetate IND accepted

NG2-73 enters clinical testing for insomnia

Dopamine reuptake inhibitor NS-2330 ineffective as a treatment for advanced Parkinson's disease

Inhibition of poly(ADP-ribose) synthase increases cardiac allograft survival

Approval for rhC1INH IND application

WinRho SDF completes European mutual recognition procedure

PRX-03140 enters phase I for Alzheimer's

Enrollment open in new phase II study of INO-1001

Monoclonal antibody may restore tamoxifen responsiveness in resistant human breast cancer cells

GTC submits responses regarding ATryn MAA

RegeneRx seeks to begin new phase II study of TB4 for venous stasis ulcers

MethylGene initiates phase I HDAC cancer study in hematological malignancies

European CHMP recommends approval of Aloxi

Encouraging data for HuMax-Inflam/MDX-018 in autoimmune study

Novel ribonuclease immunotoxin shows potent immunotoxicity in vivo

New head-to-head study compares Tysabri to Rebif

Rigel initiates phase I study of R-406

Concern over cardiovascular risk of naproxen

Genzyme completes acquisition of Ilex Oncology

sNDA filing for Attenace for ADHD

Arena forms diabetes collaboration with Ortho-McNeil

Cell Therapeutics enters Trisenox financing deal

New phase IIa study for ATL-1102 in MS

Nabi seeks European approval for StaphVAX

CB1 receptor antagonists described by Pfizer

Two series of Tie-2 modulators claimed by Exelixis

Glutamate receptor modulators described in patent literature

Scientists at Millennium claim beta-carboline compounds

Novel antibacterial carbapenems prepared and tested at Sumitomo

ChondroGene and Pfizer enter new osteoarthritis collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...